knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 21:29:04 - browse：17825

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： STAT Summit: The economic case for universal basic health care

WSS

UnitedHealth, Optum discontinue NaviHealth name

STAT Readout: Friday, Oct. 20 biotech updates

Study on Amgen’s bispecific immunotherapy produces positive data

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Judge denies Trump's request for new trial in E. Jean Carroll case

leisure time

knowledge

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

After a decade, new Gardasil ad campaign gets it (mostly) right

Virginia high school admissions case could be legal follow

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

23andMe had bad news about my health. I wish a person had delivered it

Dementia risk linked to living in disadvantaged areas: Study

Duchenne breakthrough therapy leaves behind pioneering families

Scientists grapple with ethics of stem cell research

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

leisure time

Roivant's CEO is a star, but biotech's black hole persists

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

STAT Summit: Ending the crisis of Black deaths in the U.S.

Readout LOUD podcast: Live from the 2023 STAT Summit

Sanders wants to replace patents with prizes for drug inventions

US jobless claims fall again as labor market continues to flash strength

knowledge

entertainment

focus

explore